A lot of posters need to educate when it comes to brines before...

First 19 Last

Share
Profile

Follow
zinvestor

2,917 Posts.

10/08/16

14:57

Post #: 18486953
Share

Originally posted by billyen ↑

That's more than enough.
BTW...you need to think about the chess pieces.
Mr. Alurralde is a big player as go used to run one of the big 3.

It's very early in the piece but Enirgi Group has been very slow to get things moving.
Remember to this isn't AGY's project...it's Mr. Alurralde, which AGY NOW has a big chuck of. I could easily see another bigger deal involving Enirgi.

Think about it. The game is about production.
If Mr.Alurralde can get their ops to production faster then it makes sense...Maybe this was the plan?
Oh...and let's now forget who did Enirgi's Rincon Project JORC....who the expert on their Salta?

Our own Dr.Carlos Sorentino!!!!!

I don't think any of this is a accident. I think it's a major play setting up.
It's about getting to production not about having the land. Just ask the Bolivians.
We have the 2 BIG Kings on the board to make it happen.

Think...GXY and GMMs deal. GXY needed GMM expertise is getting the lithium out and gave the 50%!

All just MHO...but......???

Expand

A lot of posters need to educate when it comes to brines before posting size I think.

We are talking aquifers that can run a thousand metres deep 100% hosting Lithium concentrate here not veins of spodumene hosted granite pegmatites that you need km and km to make economical.

AGY Price at posting: 2.4¢ Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 23 more messages in this thread...

First 19 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.001(2.63%)		Mkt cap ! $56.78M

Open	High	Low	Value	Volume
4.0¢	4.1¢	3.9¢	$303.9K	7.541M

Buyers (Bids)

No.	Vol.	Price($)
3	304999	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
3	304999	0.039
7	563206	0.038
5	648648	0.037
22	2110708	0.036
25	2513178	0.035

Price($)	Vol.	No.
0.040	25000	1
0.041	406425	2
0.042	751292	7
0.043	1956941	3
0.044	1035285	9

Last trade - 16.10pm 07/10/2024 (20 minute delay)

AGY (ASX) Chart

A lot of posters need to educate when it comes to brines before...

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

A lot of posters need to educate when it comes to brines before...

Top Stories

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News